Table 2.
|
|
|
BMI (kg/m2) at interview |
|
||
---|---|---|---|---|---|---|
No. of events | Na | ≤24.9Reference | 25–29.9HR (95% CI) | ≥30HR (95% CI) | ptrend | |
Mortality, age-adjusted | ||||||
Breast cancer-specific | ||||||
Non-Hispanic white | 62 | 297 | 1.00 | 1.02 (0.53, 1.94) | 1.97 (0.99, 3.91) | 0.09 |
Hispanic | 66 | 279 | 1.00 | 0.68 (0.36, 1.27) | 0.90 (0.47, 1.73) | 0.72 |
All-cause mortality | ||||||
Non-Hispanic white | 109 | 298 | 1.00 | 0.97 (0.60, 1.56) | 1.79 (1.04, 3.07) | 0.02 |
Hispanic | 106 | 279 | 1.00 | 0.83 (0.51, 1.38) | 1.26 (0.76, 2.10) | 0.06 |
Non–breast cancer | ||||||
Non-Hispanic white | 47 | 297 | 1.00 | 0.94 (0.46, 1.89) | 1.49 (0.58, 3.81) | 0.04 |
Hispanic | 40 | 279 | 1.00 | 1.25 (0.52, 3.00) | 2.35 (0.99, 5.62) | 0.53 |
Mortality, fully adjusted | ||||||
Breast cancer–specificb | ||||||
Non-Hispanic white | 59 | 279 | 1.00 | 0.98 (0.49, 1.96) | 2.07 (0.98, 4.35) | 0.09 |
Hispanic | 61 | 254 | 1.00 | 0.81 (0.41, 1.60) | 1.32 (0.64, 2.74) | 0.50 |
All-cause mortalityc | ||||||
Non-Hispanic white | 101 | 284 | 1.00 | 1.02 (0.62, 1.69) | 2.12 (1.15, 3.90) | 0.03 |
Hispanic | 100 | 265 | 1.00 | 0.87 (0.51, 1.48) | 1.23 (0.71, 2.12) | 0.47 |
Non–breast cancerc | ||||||
Non-Hispanic white | 41 | 283 | 1.00 | 1.02 (0.46, 2.26) | 2.65 (0.90, 7.81) | 0.15 |
Hispanic | 37 | 265 | 1.00 | 1.73 (0.63, 4.77) | 2.18 (0.77, 6.10) | 0.15 |
Number of cases included in models, one case was excluded from breast cancer–specific and non–breast cancer mortality due to unconfirmed death.
HRs adjusted for BMI at age 18, total METs, duration of estrogen use, breast cancer stage, total daily energy intake, and post–breast cancer diagnosis.
HRs adjusted for age, history of high blood pressure, history of stroke, smoking status, total METs, and total daily energy intake.
HR, hazard ratio; CI, confidence interval.